Herbal remedy for treatment of HIV infection: a preliminary report


Background: Despite availability of antiretroviral therapy (ARV), side -effects and drug resistance had been major concern thus the need to evaluate efficacy of A -Zam traditional medicine used for HIV infections

Patients and method: Nine HIV patients that consented and met the criteria were investigated, 3 sought herbal medicines as complementary while 6 as alternative therapy to HAART (4 patients discontinued HAART due to side-effects). Each HIV patient self- administered 27g of A Zam three times daily and monitored daily for possible side effects and effectiveness of the therapy, periodic CD4 count and viral load were measured.

Result: Viral load in HIV patients on complementary therapy remained undetectable but CD4 significantly (α0. 05) increased from 493±403 to 845±280 cells/µL after therapy. The viral load significantly decreased from 1,693±1691 to 55±55x103copies/ml and CD4 count increased from 564±334 to 639±280 cells/µL) in the 2 HIV patients using alternative therapy. There w as significant gradual reduction in viral load from 758±584 to 24±34x10 3copies/ml while CD4 count increased from 572±185 to 679±243 cells/µL at 180 t h day in all the 4 HIV patients that discontinued HAART but commenced A-Zam herbal medicine as alternative therapy

Conclusion: The study concluded that A-Zam is a potential effective antiviral and immune - stimulatory agent and could be used when there is HIV resistance or serious side -effects to

Keywords: Herbal medicine, Antiviral, Immune- stimulatory, HIV patients, HIV resistance

Contexte: Malgré la disponibilité de la thérapie antirétrovirale (ARV), les effets secondaires et la résistance auxmédicaments ont été une préoccupation majeure, d’où la nécessité d’évaluer l’efficacité de la médecine traditionnelle A-Zam utilisée pour les infections à VIH.

Patients et méthode: Neuf patients VIH qui ont consenti et ont répondu aux critères ont été étudiés, 3 ont recherché des médicaments à base de plantes comme complémentaires tandis que 6 comme thérapie alternative à l’HAART (4 patients ont interrompu l’HAART en raison d’effets secondaires). Chaque patient VIH s’est auto-administré 27 g de A Zam trois fois par jour et surveillé quotidiennement pour les effets secondaires possibles et l’efficacité de la thérapie, le nombre de CD4 périodique et la charge virale ont été mesurés.

Résultat: La charge virale chez les patients VIH sous thérapie complémentaire est restée indétectable mais CD4 a significativement (α0, 05) augmenté de 493 ± 403 à 845 ± 280 cellules / µL après la thérapie. La charge virale a diminué de manière significative de 1693 ± 1691 à 55 ± 55x103 copies / ml et le taux de CD4 a augmenté de 564 ± 334 à 639 ± 280 cellules / µL) chez les 2 patients VIH utilisant une thérapie alternative. Il y a eu une réduction graduelle significative de la charge virale de 758 ± 584 à 24 ± 34x103 copies / ml tandis que le nombre de CD4 a augmenté de 572 ± 185 à 679 ± 243 cellules / µL au 180ème jour chez les 4 patients VIH qui ont arrêté le traitement HAART mais ont commencé la phytothérapie A-Zam comme thérapie alternative.

Conclusion: L’étude a conclu qu’A-Zam est un potentiel agent efficace antiviral et immunostimulant, et pourrait être utilisé en cas de résistance au VIH ou d’effets secondaires graves à l’HAART.

Mots clés: Phytothérapie, Antiviral, Immunostimulant, Patients VIH, Résistance au VIH

Correspondence: Dr. A.A.Onifade, Department of Immunology, College of Medicine, University of Ibadan, Ibadan, Nigeria. E-mail: abdufattahkunle@gmail.com



UNAIDS/WHO. ‘’UNAIDS fact sheet 2019’’ pp1-6

UNAIDS/WHO. “UNAIDS Data 2017” pp. 1-3

UNAIDS/WHO. “UNAIDS fact sheet 2018” pp. 1-5.

WHO. Traditional Medicine; Growing Needs and Potential, WHO Policy Perspectives on Medicines. World Health Organization, Geneva. 2002; pp. 1–6.

Cos P, Maes L, Vlientinck A and Pieters L. Plant-derived leading compounds for chemotherapy of human immunodeficiency virus (HIV) infection- an update (1998-2007). Planta Medica 2008; 74: 1323- 1337.

Onifade AA, Jewell AP and Okesina AB. Preliminary findings of are herbal remedies effective in HIV infection in Nigeria, Tropical Journal Health Sciences 2010; 17 (2): 51-55

De Clereq. Current lead natural products for the chemotherapy of human immunodeficiency virus infection. Medical Research Review 2000; 20: 323-349.

Kong JM, Goh NK, Chia LS and Chia TF. Recent advances in traditional plant drugs and orchids, Acta Pharmacologica Sinica 2003: 24: 7-21.

Dharmaratne HRW, Tan GT, Marasinghe GPK and Pezzuto JM. Inhibition of HIV-1 reverse transcriptase and HIV-1replicationbyCalophyllum coumarins and xanthones. Planta Medica 2002; 68: 86–87.

Watson K, Gooderham NJ, Davies DS, and Edwards RJ. Interaction of the transactivating protein HIV-1 tat with sulphated polysaccharides. Biochemica Pharmacologica 1999 ;57: 775–783.

Matthee G, Wright AD and König G. HIV reverse transcriptase inhibitors of natural origin. Planta Medica 1999; 65: 493–506.

Lu WB. A report on 8 seronegative converted HIV/AIDS patients with traditional Chinese medicine. Zhongguo Zhong Xi Yi Jie He Za Zhi Zhongguo Zhongxiyi Jiehe Zazhi 1997; 17 (5):271–273. Chinese.

Elujoba AA. Medicinal plants and herbal medicines in the management of opportunistic infections in people living with HIV/AIDS, Our experience so far, being a Guest lecture presented at the National Scientific Conference organized by the Nigeria Society of Pharmacognosy (NSP) at Zaria, Nigeria. 2005; pages: 11-12.

Abere TA and Agoreyo FO. Antimicrobial and toxicological evaluation of the leaves of Baissea axillaries Hua used in the management of HIV/AIDS. BMC Complementary Alternative Medicine 2006; 21; 6: 22.

Mbah AU, Udeinya IJ, Shu EN, et al Fractionated neem leaf extracts is safe and increases CD4+ cell levels in HIV/AIDS patients. American Journal Therapeutics 2007; 14 (4):369-374.

Ahmad A., Husain A., Mujeeb M., et al., A review on therapeutic potential of Nigella sativa: A miracle herb. Asian Pacific Journal Tropical Biomedicine 2013; 3(5); 337–352.

Onifade AA, Jewell AP, and Okesina AB. Virologic and Immmunologic outcome of treatment of HIV infection with herbal concoction, α-Zam, among clients seeking herbal remedy in Nigeria. African Journal Traditional Complementary Alternative Medicine 2011; 8 (1): 37-44.

Yimer EM , Tuem KB, Karim A , Ur-Rehman N and Anwar F. Nigella sativa L. (Black Cumin): A Promising Natural Remedy for Wide Range of Illnesses. Hindawi Evidence-Based Complementary and Alternative Medicine. Volume 2019, Article ID 1528635, 16 pages https://doi.org/10.1155/2019/1528635.

Oyero OG, Toyama M, Mitsuhiro N, et al. Selective inhibition of hepatitis C virus replication by alpha-zam, a Nigella sativa seed formulation. African Journal Traditional, Complementary & Alternative Medicine 2016; 13(6): 144-148.

Oyero OG, Onifade AA and Baba M. Immunomodulatory Potential of Herbal Formulations Containing Seeds of Nigella sativa Linn. African Journal Biomedical Research 2017; 20: 217- 221.

Onifade AA., Jewell AP, Ajadi TA, Rahamon SK, and Ogunrin OO. Effectiveness of herbal remedy in 6 HIV patients in Nigeria. Journal of Herbal Medicine 2013; 3 (3): 99- 103.

Onifade AA, Jewell AP, Okesina A B, et al 5-month herbal therapy and complete seroreversion with complete recovery in an adult HIV patient. Open Access Scientific reports 2012; 1; 124.

Onifade AA, Jewell A P and Adedeji WA Nigella sativa concoction induced sustained seroreversion in HIV patient. African Journal Traditional, Complementary & Alternative Medicine 2013; 10 (5): 332-335.

Onifade AA, Jewell A P, and Okesina AB. Seronegative conversion of an HIV positive subject treated with Nigella sativa and honey. African Journal of Infectious diseases 2015; 9 (2):47 – 50

Onifade AA., Jewell AP, Okesina AB, et al. The Phytochemistry and Safety profiles of an herbal remedy α-zam used for treatment of HIV infection in Nigeria. Tropical Journal Health Sciences 2011; 18 (1): 40-45

Smurzynski M, Wu K, Benson CA, et al.. Relationship between CD4+ T-cell counts/HIV-1 RNA plasma viral load and AIDS-defining events among persons followed in the ACTG longitudinal linked randomized trials study. Journal Acquired Immune Deficiency Syndrome 2010;55(1):117-127

Engsig FN, Zangerle R, Katsarou O, et al. Long-term mortality in HIV-positive individuals virally suppressed for >3 years with incomplete CD4 recovery. Clinical Infectious Diseases 2014; 58(9):1312-1321

Moore RD and Keruly JC. CD4+ cell count 6 years after commencement of highly active antiretroviral therapy in persons with sustained virologic suppression. Clinical Infectious Diseases 2007; 44(3):441-446

Onifade AA, Oladeinde. Antimirobial effects of Nigella sativa concoction: Herbal preparation for HIV infection in Nigeria. Archive Basic Applied Medicine 2014; 2 (3): 173 – 177